Finglobenewshour offers Global Life Sciences Medical Society Conferences: Quarterly Review, an analytical compilation of key trends from the presentations made by the leading Global Life Sciences companies at medical society conferences held during the quarter just completed.
Coverage:
-
➢ Comprehensive focus on ___+ global life sciences companies that have made _____+ presentations at ___+ medical society conferences during the most recent quarter
➢ Analyzes the life sciences companies’ presentations available on company websites
➢ Provides monthly share price analysis of global life sciences companies presenting actively versus those presenting less actively and not presenting
➢ Lists the ___+ key medical society conferences covered
Key features:
-
➢ Comprehensive analysis of trends of presenters, organizers and contents presented
➢ Compares stock market performance of companies presenting actively versus those presenting less actively and not presenting
➢ Most useful for investors, mutual funds managers, corporate executives, business schools, trade associations and regulatory agencies involved with the global life sciences sector
Table of contents:
Introduction
Section 1. Analysis of ___+ global life sciences companies presented at medical society conferences during the last quarter:
1.1: By region (Africa/Middle East, Americas, Asia and Europe)
1.2: By life sciences sector sub-industries (Pharmaceuticals, Biotech, Medical Devices and Health Services)
1.3: By market capitalization (BigCap, MidCap, SmallCap and MicroCap)
1.4: By conference organizers
Section 2. Contents provided by ___+ global life sciences companies in their presentations
2.1: Financial summary related topics
2.2: Product related topics
2.3: Research related topics
2.4: Expansion related topics (diversification, mergers and acquisitions etc)
2.5: Industry and regulatory approval related topics
Section 3. Stock market performance vs. conference participation
Monthly stock price return analysis for companies actively presented during the last quarter versus those presented less actively and not presented during the quarter just completed
3.1: By region (Africa/Middle East, Americas, Asia and Europe)
3.2: By life sciences sector sub-industries (Pharmaceuticals, Biotech, Medical Devices and Health Services)
3.3: By market capitalization (BigCap, MidCap, SmallCap and MicroCap)
Appendices
Appendix A: List of ___+ conferences covered
A.1: By name
A.2: By date of conference
A.3: By country and city where held
Appendix B: List of ___+ life sciences companies covered
B.1: By region, country, and company
B.2: By sub-industry, country, and company
B.3: By market capitalization, country, and company
B.4: By conference organizers, country, and company